EUVIMEDEUVIMED entdecken
Crossref

Assessing the Impact of Posaconazole Cessation on Tacrolimus Serum Concentrations and Incident Cardiac Allograft Rejection: Take Caution

Ethan Meyer, Ravi Dhingra, Theodore Berei iD

Journal of Pharmacy Practice · 2024

DOI: 10.1177/08971900241237057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy Practice, 2024. Verfasst von Ethan Meyer und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, UW Health, Madison, WI, USA. Hauptthemen laut MEDLINE: Heart Transplantation, Triazoles, Tacrolimus, Graft Rejection. Die Arbeit nennt 4 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Invasive aspergillosis (IA) is a rare and often fatal complication of immunosuppression following orthotopic heart transplant. Prophylaxis plays a crucial role in preventing the emergence of this opportunistic infection. The azole class of medications are the bellwether agents utilized in this patient population. Unfortunately, given their impact on the Cytochrome P450 enzyme system, significant fluctuations in serum tacrolimus concentrations occur when initiating and stopping azole therapy, increasing the risk for prolonged periods of sub-optimal immunosuppression. While there are recommended dosing adjustments for these transition periods based on small data sets primarily with fluconazole, there is no published literature on recommended dosing adjustments for posaconazole. Given our institution utilizes posaconazole as the primary therapeutic for aspergillosis prophylaxis, we aimed to explore and report our local data to better guide dosing decisions during these transition periods.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart TransplantationTriazolesTacrolimusGraft RejectionAntifungal AgentsImmunosuppressive AgentsHumansAspergillosisMaleMiddle AgedFemaleDrug Interactions

Stichwörter der Autor:innen

aspergillosiscardiologyposaconazoletacrolimustransplant

Substanzen

TriazolesposaconazoleTacrolimusAntifungal AgentsImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Pharmacy, UW Health, Madison, WI, USA.
  • Division of Cardiology, Section of Advanced Heart Failure and Transplant Cardiology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

ORCID-Profile: Theodore Berei

Zitieren

APA

Meyer, E., Dhingra, R., & Berei, T. (2024). Assessing the Impact of Posaconazole Cessation on Tacrolimus Serum Concentrations and Incident Cardiac Allograft Rejection: Take Caution. Journal of Pharmacy Practice. https://doi.org/10.1177/08971900241237057

Vancouver

Meyer E, Dhingra R, Berei T. Assessing the Impact of Posaconazole Cessation on Tacrolimus Serum Concentrations and Incident Cardiac Allograft Rejection: Take Caution. Journal of Pharmacy Practice. 2024. doi:10.1177/08971900241237057

BibTeX
@article{Meyer2024,
  author = {Meyer, Ethan and Dhingra, Ravi and Berei, Theodore},
  title = {Assessing the Impact of Posaconazole Cessation on Tacrolimus Serum Concentrations and Incident Cardiac Allograft Rejection: Take Caution},
  journal = {Journal of Pharmacy Practice},
  year = {2024},
  doi = {10.1177/08971900241237057}
}
Kostenlos starten →